A detailed history of Algert Global LLC transactions in Inari Medical, Inc. stock. As of the latest transaction made, Algert Global LLC holds 44,106 shares of NARI stock, worth $2.48 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
44,106
Previous 31,926 38.15%
Holding current value
$2.48 Million
Previous $1.54 Million 18.35%
% of portfolio
0.05%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.68 - $58.62 $495,482 - $713,991
12,180 Added 38.15%
44,106 $1.82 Million
Q2 2024

Aug 14, 2024

BUY
$37.11 - $50.69 $1.18 Million - $1.62 Million
31,926 New
31,926 $1.54 Million
Q4 2023

Feb 14, 2024

BUY
$48.3 - $68.06 $185,472 - $261,350
3,840 Added 13.72%
31,833 $2.07 Million
Q3 2023

Nov 13, 2023

SELL
$54.2 - $71.67 $979,502 - $1.3 Million
-18,072 Reduced 39.23%
27,993 $1.83 Million
Q2 2023

Aug 14, 2023

BUY
$56.23 - $71.17 $1 Million - $1.27 Million
17,863 Added 63.34%
46,065 $2.68 Million
Q1 2023

May 12, 2023

BUY
$53.43 - $68.12 $1.01 Million - $1.29 Million
18,921 Added 203.87%
28,202 $1.74 Million
Q4 2022

Feb 13, 2023

SELL
$61.23 - $83.62 $90,008 - $122,921
-1,470 Reduced 13.67%
9,281 $590,000
Q3 2022

Nov 15, 2022

BUY
$65.58 - $84.69 $239,170 - $308,864
3,647 Added 51.34%
10,751 $781,000
Q2 2022

Aug 15, 2022

SELL
$52.13 - $93.81 $1.01 Million - $1.82 Million
-19,400 Reduced 73.2%
7,104 $483,000
Q1 2022

May 16, 2022

BUY
$64.92 - $99.47 $1.38 Million - $2.11 Million
21,244 Added 403.88%
26,504 $2.4 Million
Q4 2021

Feb 14, 2022

BUY
$76.51 - $93.96 $136,876 - $168,094
1,789 Added 51.54%
5,260 $480,000
Q3 2021

Nov 15, 2021

BUY
$71.29 - $95.99 $247,447 - $333,181
3,471 New
3,471 $281,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $3B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.